What is the trade name for enoxaparin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Trade Name for Enoxaparin

The trade name for enoxaparin is Lovenox (marketed as Clexane in some countries outside the United States) 1, 2, 1.

Additional Trade Name Information

Enoxaparin sodium is manufactured and marketed under several brand names globally:

  • Lovenox - Primary trade name in the United States (manufactured by Sanofi-Aventis) 1, 3
  • Clexane/Klexane - Trade name used in Europe and other international markets 2, 4, 5
  • Xaparin - Another trade name used in certain markets 4

Generic Availability

Generic versions of enoxaparin are now available in the United States. The FDA approved the first generic enoxaparin (enoxaparin sodium injection, USP) in 2010, which is considered interchangeable with branded Lovenox for all approved indications 6. Multiple manufacturers now produce generic enoxaparin formulations 7, 8.

Important Clinical Consideration

While generic enoxaparin has been approved as equivalent to Lovenox, it's worth noting that different low-molecular-weight heparins (such as dalteparin/Fragmin and tinzaparin/Innohep) are NOT clinically interchangeable with enoxaparin, as they are prepared by different depolymerization methods and have distinct pharmacokinetic properties 2.

References

Research

Lovenox Induced Tissue Necrosis, a Case Report and Literature Review.

The journal of the American College of Clinical Wound Specialists, 2013

Research

The United States Food and Drugs Administration approves a generic enoxaparin.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2011

Research

Comparative studies on branded enoxaparin and a US generic version of enoxaparin.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.